Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2013

01.02.2013 | Research Article

Off-label drug prescribing in a Portuguese Paediatric Emergency Unit

verfasst von: Marina Ribeiro, Arminda Jorge, Ana Filipa Macedo

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background Many drugs are prescribed outside the terms of the marketing authorization (“off-label”). Several studies have shown that this is a common practice in various European healthcare settings. Objective This study aimed to quantify and characterize off-label drug prescribing in children admitted to a Portuguese Paediatric Unit (PEU). Setting This study was conducted in the Paediatric Unit of the university teaching hospital of Cova da Beira Hospital Centre (CHCB), Covilhã, located in the Eastern Central Region of Portugal. Method A descriptive study was conducted, including a sample of 700 children, randomly selected from those admitted between January to October 2010. Drug prescription was assessed by retrospective review of clinical files. Main outcome measure Off-label prescribing was defined as the utilization of a drug at an indication, age, dosage, frequency or route of administration different from those recommended in the Summary of Product Characteristics (SPC). For purposes of this study only the medicines prescribed to be used after discharge from the hospital were studied. Results 364 boys and 336 girls, aged from 4 days to 18 years, were included in this study. Of the 724 medicines prescribed, 32.2 % were off-label. At least one drug was used off-label in 28.1 % of the studied population, corresponding to 46.1 % of the 427 children that received prescriptions. “Alteration in dosage” was the commonest reason for off-label prescribing (28.2 %). The off-label prescriptions comprised mainly drugs acting on the “Respiratory System” and “Anti-infectious agents for systemic use”. Amoxicillin/clavulanic acid, paracetamol, amoxicillin, ibuprofen and salbutamol were the five active principles most frequently prescribed off-label. Conclusion The prevalence of off-label drug prescribing in the Portuguese PEU of CHCB is high, the use in a dose or for an age group not approved in the SPC being the most common reasons for off-label prescription.
Literatur
1.
Zurück zum Zitat Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al. Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly. 2006;136(13–14):218–22.PubMed Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al. Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly. 2006;136(13–14):218–22.PubMed
2.
Zurück zum Zitat Muhlbauer B, Janhsen K, Pichler J, Schoettler P. Off-label use of prescription drugs in childhood and adolescence: an analysis of prescription patterns in Germany. Dtsch Arztebl Int. 2009;106(3):25–31.PubMed Muhlbauer B, Janhsen K, Pichler J, Schoettler P. Off-label use of prescription drugs in childhood and adolescence: an analysis of prescription patterns in Germany. Dtsch Arztebl Int. 2009;106(3):25–31.PubMed
3.
Zurück zum Zitat Yaffe SJ, Aranda JV. Neonatal and pediatric pharmacology: therapeutic principles in practice. 4th ed. Philadelphia: WB Saunders; 2010. ISBN: 9780781795388. Yaffe SJ, Aranda JV. Neonatal and pediatric pharmacology: therapeutic principles in practice. 4th ed. Philadelphia: WB Saunders; 2010. ISBN: 9780781795388.
4.
Zurück zum Zitat Duarte D. Medicamentos para Crianças A realidade actual na União Europeia. Revista Lusófona de Ciências e Tecnologia da Saúde. 2006;3(1):9–18. Duarte D. Medicamentos para Crianças A realidade actual na União Europeia. Revista Lusófona de Ciências e Tecnologia da Saúde. 2006;3(1):9–18.
5.
Zurück zum Zitat Venitz J, Sittner We. Appropriate dose selection—how to optimize clinical drug development. Vol. 59. Springer; 2007. p. 111–134. Venitz J, Sittner We. Appropriate dose selection—how to optimize clinical drug development. Vol. 59. Springer; 2007. p. 111–134.
6.
Zurück zum Zitat Meadows M. Drug research and children. FDA Consum. 2003;37(1):12–7. Meadows M. Drug research and children. FDA Consum. 2003;37(1):12–7.
7.
Zurück zum Zitat Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O. Utilisation hors autorisation de mise sur le marché (AMM) des psychotropes en pédiatrie: une étude prospective. Arch Pediatr. 2009;16(9):1252–60.PubMedCrossRef Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O. Utilisation hors autorisation de mise sur le marché (AMM) des psychotropes en pédiatrie: une étude prospective. Arch Pediatr. 2009;16(9):1252–60.PubMedCrossRef
8.
Zurück zum Zitat Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children. Fundam Clin Pharmacol. 2003;17(3):281–99.PubMedCrossRef Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children. Fundam Clin Pharmacol. 2003;17(3):281–99.PubMedCrossRef
9.
Zurück zum Zitat Kimland E, Bergman U, Lindemalm S, Bottiger Y. Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr. 2007;166(6):527–32.PubMedCrossRef Kimland E, Bergman U, Lindemalm S, Bottiger Y. Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr. 2007;166(6):527–32.PubMedCrossRef
10.
Zurück zum Zitat Novak E, Allen PJ. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics. Pediatr Nurs. 2007;33(1):64–70.PubMed Novak E, Allen PJ. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics. Pediatr Nurs. 2007;33(1):64–70.PubMed
11.
Zurück zum Zitat Johnson TN. The problems in scaling adult drug doses to children. Arch Dis Child. 2008;93(3):207–11.PubMedCrossRef Johnson TN. The problems in scaling adult drug doses to children. Arch Dis Child. 2008;93(3):207–11.PubMedCrossRef
14.
Zurück zum Zitat Autret-Leca E, Bensouda-Grimaldi L, Le Guellec C, Jonville-Béra AP. L’enfant et les médicaments: application à la prescription en pédiatrie. Archives de Pédiatrie. 2005;13:181–5.PubMedCrossRef Autret-Leca E, Bensouda-Grimaldi L, Le Guellec C, Jonville-Béra AP. L’enfant et les médicaments: application à la prescription en pédiatrie. Archives de Pédiatrie. 2005;13:181–5.PubMedCrossRef
15.
Zurück zum Zitat Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552–8.PubMedCrossRef Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552–8.PubMedCrossRef
16.
Zurück zum Zitat Gazarian M, Kelly M, McPhee JR, Graudins LV, Ward RL, Campbell TJ. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006;185(10):544–8.PubMed Gazarian M, Kelly M, McPhee JR, Graudins LV, Ward RL, Campbell TJ. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006;185(10):544–8.PubMed
17.
Zurück zum Zitat McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child. 2000;83(6):498–501.PubMedCrossRef McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child. 2000;83(6):498–501.PubMedCrossRef
18.
Zurück zum Zitat Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88(9):965–8.PubMedCrossRef Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88(9):965–8.PubMedCrossRef
19.
Zurück zum Zitat Jonville-Bera AP, Bera F, Autret-Leca E. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol. 2005;61(3):231–6.PubMedCrossRef Jonville-Bera AP, Bera F, Autret-Leca E. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol. 2005;61(3):231–6.PubMedCrossRef
20.
Zurück zum Zitat Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ. 2000;320(7227):79–82.PubMedCrossRef Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ. 2000;320(7227):79–82.PubMedCrossRef
21.
Zurück zum Zitat Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C Jr, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3):282–90.PubMedCrossRef Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C Jr, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3):282–90.PubMedCrossRef
22.
Zurück zum Zitat Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther. 2009;34(3):277–87.PubMedCrossRef Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther. 2009;34(3):277–87.PubMedCrossRef
23.
Zurück zum Zitat Morales-Carpi C, Estan L, Rubio E, Lurbe E, Morales-Oliva FJ. Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol. 2010;66:315–20.PubMedCrossRef Morales-Carpi C, Estan L, Rubio E, Lurbe E, Morales-Oliva FJ. Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol. 2010;66:315–20.PubMedCrossRef
27.
Zurück zum Zitat Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665–70.PubMedCrossRef Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665–70.PubMedCrossRef
28.
Zurück zum Zitat Jain SS, Bavdekar SB, Gogtay NJ, Sadawarte PA. Off-label drug use in children. Indian J Pediatr. 2008;75(11):1133–6.PubMedCrossRef Jain SS, Bavdekar SB, Gogtay NJ, Sadawarte PA. Off-label drug use in children. Indian J Pediatr. 2008;75(11):1133–6.PubMedCrossRef
29.
Zurück zum Zitat Bajcetic M, Jelisavcic M, Mitrovic J, Divac N, Simeunovic S, Samardzic R, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61(10):775–9.PubMedCrossRef Bajcetic M, Jelisavcic M, Mitrovic J, Divac N, Simeunovic S, Samardzic R, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61(10):775–9.PubMedCrossRef
30.
Zurück zum Zitat ‘t Jong GW, Eland IA, Sturkenboom MC, van den Arker JN, Strickerf BH. Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J. 2004;23(2):310–3.PubMedCrossRef ‘t Jong GW, Eland IA, Sturkenboom MC, van den Arker JN, Strickerf BH. Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J. 2004;23(2):310–3.PubMedCrossRef
31.
Zurück zum Zitat Hsien L, Breddemann A, Frobel AK, Heusch A, Schmidt KG, Laer S. Off-label drug use among hospitalised children: identifying areas with the highest need for research. Pharm World Sci. 2008;30(5):497–502.PubMedCrossRef Hsien L, Breddemann A, Frobel AK, Heusch A, Schmidt KG, Laer S. Off-label drug use among hospitalised children: identifying areas with the highest need for research. Pharm World Sci. 2008;30(5):497–502.PubMedCrossRef
33.
Zurück zum Zitat ‘t Jong G, Eland IA, Strickerf BH, van den Anker JN. Information for paediatric use of medicines in a product information compendium. Paediatr Perinatal Drug Ther. 2001;4(4):148–51. ‘t Jong G, Eland IA, Strickerf BH, van den Anker JN. Information for paediatric use of medicines in a product information compendium. Paediatr Perinatal Drug Ther. 2001;4(4):148–51.
34.
Zurück zum Zitat Smith AR, Barbato A, Beydon N, Bisgaard H, de Boeck K, Brand P, et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J. 2010;35:247–65.CrossRef Smith AR, Barbato A, Beydon N, Bisgaard H, de Boeck K, Brand P, et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J. 2010;35:247–65.CrossRef
Metadaten
Titel
Off-label drug prescribing in a Portuguese Paediatric Emergency Unit
verfasst von
Marina Ribeiro
Arminda Jorge
Ana Filipa Macedo
Publikationsdatum
01.02.2013
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2013
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9699-y

Weitere Artikel der Ausgabe 1/2013

International Journal of Clinical Pharmacy 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.